Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18553/jmcp.2020.19306

PubMed Identifier: 32191592

Publication URI: http://europepmc.org/abstract/MED/32191592

Type: Journal Article/Review

Volume: 26

Parent Publication: Journal of managed care & specialty pharmacy

Issue: 5

ISSN: 2376-0540